eli lilly pill glp 1 Oral GLP-1 Orforglipron Is Approved for Obesity Eli Lilly Weight-Loss Pill Shows

A retrospective, population-based cohort study found that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was safe and associated with lower risks of cardiovascular or psychiatric comorbidities and lower mortality among patients with psoriasis

Decreased mortality, anti-inflammatory properties and neuroprotective effects can be beneficial in chronic substance use which is associated with neuroinflammation and oxidative stress

Neurochem Int 2007

What happens to my weight after stopping GLP-1 treatment

[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Zhu E, et al

FIGURE 4 In a third group in this study, the same quantity of exendin-4 was administered via the intestine co-formulated in the Axcess formulation with recombinant human insulin